(Q34365617)

English

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Salim I. Khakoo

object named as

Salim I Khakoo

11

0 references

author name string

Susanne Knapp

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Usama Warshow

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Doha Hegazy

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Louise Brackenbury

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

I Neil Guha

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andrew Fowell

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ann-Margaret Little

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Graeme J Alexander

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

William M C Rosenberg

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Matthew E Cramp

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1168-1175

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Genetic factors predicting response to interferon treatment for viral hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

HLA alleles determine differences in human natural killer cell responsiveness and potency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Human NK cell education by inhibitory receptors for MHC class I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Host factors and failure of interferon-alpha treatment in hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Human diversity in killer cell inhibitory receptor genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Killer cell inhibitory receptors: diversity, specificity, and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

6 July 2018

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Immunology. NK cells lose their inhibition

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23477

21 January 2018

The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

27 October 2018

Sequencing protocols for detection of HLA class I polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202114

9 December 2018

Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20077564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

1 reference

https://pubmed.ncbi.nlm.nih.gov/20077564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/20077564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/HEP.23477

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34365617&oldid=1548871268"